Prior Stephen David
Insider CIK 2042268 · ANTX Chief Strategy Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANTX AN2 Therapeutics, Inc. | S Sale | 2026-01-06 | 2026-01-07 | 2,858 | $1.01 | $2.9K | 59,086 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-07 | 3,604 | $1.00 | $3.6K | 61,944 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2025-11-04 | 2025-11-06 | 765 | $1.14 | $872 | 65,548 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2025-02-26 | 2025-02-28 | 56,000 | — | $0 | 56,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2025-02-26 | 2025-02-28 | 28,000 | — | $0 | 61,313 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2025-01-03 | 2025-01-07 | 2,029 | $1.34 | $2.7K | 33,313 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2024-11-04 | 2024-11-05 | 20,250 | — | $0 | 20,250 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2024-11-04 | 2024-11-05 | 10,125 | — | $0 | 35,342 | SEC↗ |